• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comparing tapentadol to oxycodone/naloxone combination: building castles in the air.

作者信息

Scarpignato Carmelo, Gatta Luigi

出版信息

Curr Med Res Opin. 2015 Feb;31(2):335-8. doi: 10.1185/03007995.2014.957823. Epub 2014 Sep 9.

DOI:10.1185/03007995.2014.957823
PMID:25166457
Abstract
摘要

相似文献

1
Comparing tapentadol to oxycodone/naloxone combination: building castles in the air.将曲马多与羟考酮/纳洛酮组合进行比较：白日做梦。
Curr Med Res Opin. 2015 Feb;31(2):335-8. doi: 10.1185/03007995.2014.957823. Epub 2014 Sep 9.
2
Comparing tapentadol to oxycodone/naloxone combination: imagining castles in the air … while building sandcastles! Re: Coluzzi F, Ruggeri M. Clinical and economic evaluation of tapentadol extended release and oxycodone/naloxone extended release in comparison with controlled release oxycodone in musculoskeletal pain. Curr Med Res Opin 2014;30:1139-51.将曲马多与羟考酮/纳洛酮组合进行比较：幻想空中楼阁……实则在建造沙堡！回复：科卢齐 F，鲁杰里 M。与控释羟考酮相比，曲马多缓释片和羟考酮/纳洛酮缓释片在肌肉骨骼疼痛中的临床和经济学评价。《当前医学研究与观点》2014 年；30:1139 - 51。
Curr Med Res Opin. 2015 Feb;31(2):339-42. doi: 10.1185/03007995.2014.971361. Epub 2014 Nov 7.
3
Clinical and economic evaluation of tapentadol extended release and oxycodone/naloxone extended release in comparison with controlled release oxycodone in musculoskeletal pain.与控释羟考酮相比，曲马多缓释片和羟考酮/纳洛酮缓释片用于肌肉骨骼疼痛的临床及经济学评价
Curr Med Res Opin. 2014 Jun;30(6):1139-51. doi: 10.1185/03007995.2014.894501. Epub 2014 Mar 3.
4
Impact of prolonged-release oxycodone/naloxone on outcomes affecting patients' daily functioning in comparison with extended-release tapentadol: a systematic review.与缓释曲马多相比，缓释羟考酮/纳洛酮对影响患者日常功能结局的影响：一项系统评价。
Clin Ther. 2015 Jan 1;37(1):212-24. doi: 10.1016/j.clinthera.2014.12.001.
5
Budget impact analysis of tapentadol extended release for the treatment of moderate to severe chronic noncancer pain.盐酸他喷他多缓释片治疗中重度慢性非癌痛的预算影响分析。
Clin Ther. 2013 May;35(5):659-72. doi: 10.1016/j.clinthera.2013.03.016. Epub 2013 Apr 13.
6
Effectiveness of Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR for the Management of Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open-Label, Phase 3b/4 Study.与羟考酮/纳洛酮缓释片相比，曲马多缓释片治疗伴有神经病理性成分的重度慢性下腰痛的有效性：一项随机、对照、开放标签的3b/4期研究。
Pain Pract. 2016 Jun;16(5):580-99. doi: 10.1111/papr.12308. Epub 2015 Jun 12.
7
Combatting pain after orthopedic/trauma surgery- perioperative oral extended-release tapentadol vs. extended-release oxycodone/naloxone.骨科/创伤手术后疼痛的治疗——围手术期口服缓释曲马多与缓释羟考酮/纳洛酮对比
BMC Anesthesiol. 2017 Jul 11;17(1):91. doi: 10.1186/s12871-017-0383-6.
8
Clinical simulation model of long-acting opioids for treatment of chronic non-cancer pain in the United States.美国长效阿片类药物治疗慢性非癌痛的临床模拟模型。
J Med Econ. 2013;16(2):307-17. doi: 10.3111/13696998.2012.756401. Epub 2012 Dec 14.
9
Cost-effectiveness of tapentadol prolonged release compared with oxycodone controlled release in the UK in patients with severe non-malignant chronic pain who failed 1st line treatment with morphine.在英国，对于一线治疗药物吗啡治疗失败的严重非恶性慢性疼痛患者，与羟考酮控释片相比，曲马多缓释片的成本效益。
J Med Econ. 2012;15(4):724-36. doi: 10.3111/13696998.2012.670174. Epub 2012 Mar 28.
10
[Tapentadol prolonged release improves analgesia, functional impairment and quality of life in patients with chronic pain who have previously received oxycodone/naloxone].[曲马多缓释片可改善既往接受羟考酮/纳洛酮治疗的慢性疼痛患者的镇痛效果、功能障碍及生活质量]
MMW Fortschr Med. 2014 Jul 24;156 Suppl 2:54-63.

引用本文的文献

1
Tapentadol Versus Tramadol: A Narrative and Comparative Review of Their Pharmacological, Efficacy and Safety Profiles in Adult Patients.曲马多与酒石酸布托啡诺：成人患者药物疗效和安全性的比较综述。
Drugs. 2021 Jul;81(11):1257-1272. doi: 10.1007/s40265-021-01515-z. Epub 2021 Jul 1.
2
[Incidence of constipation in patients with outpatient opioid therapy].[门诊阿片类药物治疗患者便秘的发生率]
Schmerz. 2016 Apr;30(2):158-65. doi: 10.1007/s00482-015-0018-0.
3
Pain in the Frail or Elderly Patient: Does Tapentadol Have a Role?体弱或老年患者的疼痛：曲马多有作用吗？
Drugs Aging. 2015 Jun;32(6):419-26. doi: 10.1007/s40266-015-0268-7.